Kinuu is a digital health company striving to combat learning disabilities such as ADD/HD, Dyslexia, and Autism through advanced brain training. The company's signature game, BrainyAct®, is at the core of their program, integrating cutting-edge technology, proven clinical programs, and neuroscience to enhance and harmonize the brain's primary functions for individuals aged 6-30. Founded in 2014, Kinuu stands for changing the outcomes for millions of children, aiming to restore hope to families for a better tomorrow. The company operates at the intersection of technology, healthcare, and education, addressing a significant and underserved market segment. With a focus on leveraging innovative solutions to address pressing societal issues, Kinuu presents an intriguing investment opportunity for venture capitalists looking to support transformative initiatives in the health-tech space.
There is no investment information
No recent news or press coverage available for Kinuu.